HBFOTC FILING WATCHBY HONGBO FINANCELIVE WIREOFFICIAL SEC RECORDS · FINRA OTC DAILY LIST
公司公告

HUTCHMED Announces Expanded Coverage on National Reimbursement Drug List for ELUNATE ® and ORPATHYS ®

HUTCHMED (China) Ltd · HMDCF

原披露日期:;精度:秒。

来源:SEC(SEC EDGAR 6-K)。

查看原始披露 ↗

查看已提交的公告附件 ↗

融资准备壳资料工具

原文限定:The government in China has placed great importance on improving the affordability of drug treatments for the public. As of end of 2025, 1.33 billion people in China had basic medical insurance coverage, representing around 95% of the entire population. The NRDL is updated every year, and inclusion on the list is subject to renewal every two years. The NHSA annually convenes a broad network of experts in medicine, pharmacology, pharmacoeconomics and actuarial valuation to identify innovative medicines to consider for NRDL inclusion. Reimbursement of Category B medicines, including novel oncology medicines, requires varying degrees of copayment from patients, depending on their provinces or types of NHSA insurance scheme enrollment.

标题保留原文的计划、申请、条件、初步结果及否定状态,以原文为准。本站核验来源归属、证券身份及披露时间,不保证公司陈述或投资价值。

核验记录与处理时间

来源原始时间字段:2026-11-16T11:02:24.000Z;日期依据:SEC accepted filing time (Atom and index checked); calendar date is America/New_York; not an inferred press-release time。

采集层首次发现:2026-11-16T11:45:49.327Z;事件路径观察:2026-11-16T11:46:13.141Z。

处理开始:2026-11-17T04:16:05.902Z;处理完成:2026-11-17T04:16:08.918Z;首次资格通过:2026-11-17T04:16:08.918Z;首次公开:2026-11-17T04:16:08.918Z。

公开模式:natural_new;处理方式:automatic;规则版本:sec_company_events_v3_filed_release;自然时槽:2026-11-17T04:15:23.513Z。

保留原始披露及首次时间,重新展示不重写发布时间。

公司身份依据 · OTC市场依据

身份核验记录:2026-11-17T04:16:07.192Z;来源核验记录:2026-11-17T04:16:07.192Z。